Table Of Content

Cancer Letters, 62 (1992) 27—72 8 0 Elsevier Scientific Publishers Ireland Ltd. Subject Index Volume 62 2-Amino-3,4-dimethylimidazo[4,5-f]quinoline, Ha-ras BOP, cholecystokinin, Syrian golden hanster, pancreatic mutation, forestomach squamous cell carcinoma, 115 neoplasm, DNA aklyation, 251 2-Acetylaminofluorene, benzo[a]pyrene, 4-aminobiphenyl, Burns, tumorigenicity, cultured keratinocytes, serum-free human, rat, hepatocytes, DNA adducts and *P- medium, cultured skin grafts, skin carcinoma, 141 postlabeling assay, 87 Acute lymphoid leukemia, acute myeloid leukemia, c-myc, colon, oncogene, proto-oncogene, induction and manganese-superoxide dismutase, 211 differentiation agents, 95 Acute myeloid leukemia, acute lymphoid leukemia, Carbaryl, mouse skin, carcinogenicity, cocarcinogenicity, manganese-superoxide dismutase, 211 133 Aflatoxin B,, penta-acetyl geniposide, genotoxicity, Carcinogenicity, carbaryl, mouse skin, cocarcinogenicity, cytotoxicity, 233 133 Alprazolam, stress, mammary tumor virus, immunity, anx- Cashew nut shell oil, papilloma, mouse skin, 149 iolytics, 185 cDNA, laminin, receptor, human, lung cancer, 199 4-Aminobiphenyl, 2-acetylaminofluorene, benzo[a]pyrene, Cell cycle, oncogenes, mastocytes, interleukin-3, flow human, rat, hepatocytes, DNA adducts and *P- cytometry, 243 postlabeling assay, 87 Cell differentiation, HL-60 cells, protein kinase C, radicals, Angiogenesis, ovarian cancer, ascitic fluid, macrophages, asbestos, 225 endothelial cells, 153 Chinese medicinal herbs, Oldenlandia diffusa, Scutellaria Anti-cancer antibody, human monoclonal antibody, an- barbata, BaP 7,8-DHD and BPDE metabolism, DNA tibody dependent cell-mediated cytotoxicity, tumor im- binding, mutagenesis, scavenging, 123 munity, cytotoxicity, effector cell, 179 Chlorination by-products, trichloroacetonitrile, halogenated Antibody dependent cell-mediated cytctoxicity, human acetonitriles, DNA adduct, protein adduct, 1 monoclonal antibody, anti-cancer antibody, tumor im- Cholecystokinin, Syrian golden hanster, pancreatic munity, cytotoxicity, effector cell, 179 neoplasm, DNA aklyation, BOP, 251 Antiproliferative effect, transformed cell lines, retinoids, Cisplatin resistance, thaliblastine, collateral sensitivity, rat cytokines, combination therapy, 167 ovarian tumor cell lines, 173 Anxiolytics, stress, mammary tumor virus, immunity, Cocarcinogenicity, carbaryl, mouse skin, carcinogenicity, alprazolam, 185 133 Asbestos, HL-60 cells, cell differentiation, protein kinase Collateral sensitivity, thaliblastine, cisplatin resistance, rat C, radicals, 225 ovarian tumor cell lines, 173 Ascitic fluid, ovarian cancer, macrophages, endothelial Colon, c-myc, oncogene, proto-oncogene, induction and cells, angiogenesis, 153 differentiation agents, 95 Autorcine loop, insulin-like growth factor I, suramin, dif- Combination therapy, antiproliferative effect, transform- ferentiation, human colon cancer cells, 23 ed cell lines, retinoids, cytokines, 167 Cultured keratinocytes, tumorigenicity, serum-free BaP 7,8-DHD and BPDE metabolism, Chinese medicinal medium, cultured skin grafts, burns, skin carcinoma, herbs, Oldenlandia diffusa, Scutellaria barbata, DNA 141 binding, mutagenesis, scavenging, 123 Cultured skin grafts, tumorigenicity, cultured keratinocytes, Benzo[a]pyrene, 2-acetylaminofluorene, 4-aminobipheny], serum-free medium, burns, skin carcinoma, 141 human, rat, hepatocytes, DNA adducts and =p: Cytokines, antiproliferative effect, transformed cell lines, postlabeling assay, 87 retinoids, combination therapy, 167 278 Cytotoxicity, human monoclonal antibody, antibody Ha-ras mutation, 2-amino-3,4-dimethylimidazo[4,5-f]- dependent cell-mediated cytotoxicity, anti-cancer an- quinoline, forestomach squamous cell carcinoma, 115 tibody, tumor immunity, effector cell, 179 Halogenated acetonitriles, trichloroacetonitrile, chlorina- Cytotoxicity, penta-acetyl geniposide, genotoxicity, aflatox- tion by-products, DNA adduct, protein adduct, 1 in B,, 233 HeLa, cytotoxic effect, Raji, flavonoids, polyphenols, fat- Cytotoxic effect, HeLa, Raji, flavonoids, polyphenols, fat- soluble vitamins, 217 soluble vitamins, 217 Hepatocytes, 2-acetylaminofluorene, benzo[a]pyrene, 4-aminobiphenyl, human, rat, DNA adducts and *“P- Dietary components, fecapentaenes, fecal mutagenicity, postlabeling assay, 87 vegetarians, omnivores, 11 HL-60 cells, cell differentiation, protein kinase C, radicals, Differentiation, insulin-like growth factor I, suramin, autor- asbestos, 225 cine loop, human colon cancer cells, 23 Human, 2-acetylaminofluorene, benzo[a]pyrene, Distribution, naticarcinogenesis, protease inhibitor, 191 4-aminobiphenyl, rat, hepatocytes, DNA adducts and DNA adduct, trichloroacetonitrile, halogenated 32P_postlabeling assay, 87 acetonitriles, chlorination by-products, protein adduct, Human, laminin, receptor, lung cancer, cDNA, 199 1 Human colon cancer cells, insulin-like growth factor I, DNA adducts and *P-postlabeling assay, 2-acetyl- suramin, autorcine loop, differentiation, 23 aminofluorene, benzo[a]pyrene, 4-aminobiphenyl, Human monoclonal antibody, antibody dependent cell- human, rat, hepatocytes, 87 mediated cytotoxicity, anti-cancer antibody, tumor im- DNA aklyation, cholecystokinin, Syrian golden hanster, munity, cytotoxicity, effector cell, 179 pancreatic neoplasm, BOP, 251 DNA binding, Chinese medicinal herbs, Oldenlandia dif- Immunity, stress, mammary tumor virus, alprazolam, anx- fusa, Scutellaria barbata, BaP 7,8-DHD and BPDE metabolism, mutagenesis, scavenging, 123 iolytics, 185 Immunotherapy, gene transfer, interleukin-2, interleukin-4, Drug transport, multidrug resistance, P-glycoprotein, pro- 257 tein kinase C isoforms, 69 Induction and differentiation agents, c-myc, colon, on- Effector cell, human monoclonal antibody, antibody cogene, proto-oncogene, 95 Insulin-like growth factor I, suramin, autorcine loop, dif- dependent cell-mediated cytotoxicity, anti-cancer antibody, tumor immunity, cytotoxicity, 179 ferentiation, human colon cancer cells, 23 Endothelial cells, ovarian cancer, ascitic fluid, Interleukin-2, immunotherapy, gene transfer, interleukin-4, macrophages, angiogenesis, 153 257 Interleukin-3, oncogenes, mastocytes, cell cycle, flow cytometry, 243 F-344, spontaneous, neoplams, tumor, rat, rodent, 49 Fat, vitamin A, lung carcinogenesis, N-nitrosodiethylamine, Interleukin-4, immunotherapy, gene transfer, interleukin-2, 57 257 Isothiocyanates, phenethyl isothiocyanate (PEITC), Fat-soluble vitamins, cytotoxic effect, HeLa, Raji, 6-phenylhexyl isothiocyanate (PHITC), tobacco-specific flavonoids, polyphenols, 217 nitrosoamine, 4-(methylnitrosamino)-1-(3-pyridy]l) Fecal mutagenicity, fecapentaenes, dietary components, vegetarians, omnivores, 11 1-butanone (NNK), 77 Fecapentaenes, fecal mutagenicity, dietary components, vegetarians, omnivores, 11 Labeling indices, magnesium hydroxide, methylazox- Flavonoids, cytotoxic effect, HeLa, Raji, polyphenols, fat- ymethanol acetate, large bowel carcinogenesis, 43 soluble vitamins, 217 Laminin, receptor, human, lung cancer, cDNA, 199 Flow cytometry, oncogenes, mastocytes, cell cycle, Large bowel carcinogenesis, magnesium hydroxide, interleukin-3, 243 methylazoxymethanol acetate, labeling indices, 43 Forestomach squamous cell carcinoma, 2-amino-3,4- Liver, serotonin (5-HT), tumour cells, phagocytes, lodge- dimethylimidazo{4,5-f]quinoline, Ha-ras mutation, 115 ment, 83 Lodgement, serotonin (5-HT), tumour cells, phagocytes, Gene transfer, immunotherapy, interleukin-2, liver, 83 interleukin-4, 257 Lung cancer, laminin, receptor, human, cDNA, 199 Genotoxicity, penta-acetyl geniposide, cytotoxicity, aflatox- Lung carcinogenesis, vitamin A, fat, N-nitrosodiethyl- in B,, 233 amine, 57 279 Macrophages, ovarian cancer, ascitic fluid, endothelial Pancreatic cancer somatostatin analog carrying cytotoxic cells, angiogenesis, 153 radical somatostatin methotrexate 263 Magnesium hydroxide, methylazoxymethanol acetate, Pancreatic neoplasm, cholecystokinin, Syrian golden large bowel carcinogenesis, labeling indices, 43 hanster, DNA aklyation, BOP, 251 Mammary tumor virus, stress, immunity, alprazolam, anx- Papilloma, cashew nut shell oil, mouse skin, 149 iolytics, 185 Penta-acetyl geniposide, genotoxicity, cytotoxicity, aflatox- Manganese-superoxide dismutase, acute myeloid in B,, 233 leukemia, acute lymphoid leukemia, 211 Phagocytes, serotonin (5-HT), tumour cells, liver, lodge- Mastocytes, oncogenes, cell cycle, interleukin-3, flow ment, 83 cytometry, 243 Phenethyl isothiocyanate (PEITC), isothiocyanates, Methotrexate pancreatic cancer somatostatin analog car- 6-phenylhexyl isothiocyanate (PHITC), tobacco-specific rying cytotoxic radical somatostatin 263 nitrosoamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1- Methylazoxymethanol acetate, magnesium hydroxide, butanone (NNK), 77 large bowel carcinogenesis, labeling indices, 43 6-Phenylhexyl isothiocyanate (PHITC), isothiocyanates, 4,4’-Methylene bis(2-chloraniline) (MOCA), ornithine phenethyl isothiocyanate (PEITC), tobacco-specific decarboxylase, 63 nitrosoamine, 4-(methylnitrosamino)-1-(3-pyridyl)- 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNk), 1-butanone (NNK), 77 isothiocyanates, phenethyl isothiocyanate (PEITC), Polyphenols, cytotoxic effect, HeLa, Raji, flavonoids, fat- 6-phenylhexyl isothiocyanate (PHITC), tobacco-specific soluble vitamins, 217 nitrosoamine, 77 Promotion, skin, tumor, sphingosine, 35 Mezerein, SHE clonal transformation, tumor promoter, Protease inhibitor, naticarcinogenesis, distribution, 191 159 Protein adduct, trichloroacetonitrile, halogenated Mouse skin, carbaryl, carcinogenicity, cocarcinogenicity, acetonitriles, chlorination by-products, DNA adduct, 1 133 Protein kinase C, HL-60 cells, cell differentiation, radicals, Mouse skin, cashew nut shell oil, papilloma, 149 asbestos, 225 Multidrug resistance, drug transport, P-glycoprotein, pro- Protein kinase C isoforms, multidrug resistance, drug tein kinase C isoforms, 69 transport, P-glycoprotein, 69 Mutagenesis, Chinese medicinal herbs, Oldenlandia dif- Proto-oncogene, c-myc, colon, oncogene, induction and fusa, Scutellaria barbata, BaP 7,8-DHD and BPDE differentiation agents, 95 metabolism, DNA binding, scavenging, 123 Radicals, HL-60 cells, cell differentiation, protein kinase Naticarcinogenesis, distribution, protease inhibitor, 191 C, asbestos, 225 Raji, cytotoxic effect, HeLa, flavonoids, polyphenols, fat- Neoplams, spontaneous, tumor, F-344, rat, rodent, 49 soluble vitamins, 217 N-Nitrosodiethylamine, vitamin A, fat, lung carcinogenesis, Rat, 2-acetylaminofluorene, benzo[a]pyrene, 4-amino- oy biphenyl, human, hepatocytes, DNA adducts and ne postlabeling assay, 87 Oldenlandia diffusa, Chinese medicinal herbs, Scutellaria Rat, spontaneous, neoplams, tumor, F-344, rodent, 49 barbata, BaP 7,8-DHD and BPDE metabolism, DNA Rat ovarian tumor cell lines, thaliblastine, cisplatin binding, mutagenesis, scavenging, 123 resistance, collateral sensitivity, 173 Omnivores, fecapentaenes, fecal mutagenicity, dietary Receptor, laminin, human, lung cancer, cDNA, 199 components, vegetarians, 11 Retinoids, antiproliferative effect, transformed cell lines, Oncogene, c-myc, colon, proto-oncogene, induction and cytokines, combination therapy, 167 differentiation agents, 95 Rodent, spontaneous, neoplams, tumor, F-344, rat, 49 Oncogenes, mastocytes, cell cycle, interleukin-3, flow cytometry, 243 Scavenging, Chinese medicinal herbs, Oldenlandia diffusa, Ornithine decarboxylase, 4,4’-methylene bis(2-chlor- Scutellaria barbata, BaP 7,8-DHD and BPDE aniline) (MOCA), 63 metabolism, DNA binding, mutagenesis, 123 Ovarian cancer, ascitic fluid, macrophages, endothelial Scutellaria barbata, Chinese medicinal herbs, Oldenlan- cells, angiogenesis, 153 dia diffusa, BaP 7,8-DHD and BPDE metabolism, DNA binding, mutagenesis, scavenging, 123 P-glycoprotein, multidrug resistance, drug transport, pro- Serotonin (5-HT), tumour cells, phagocytes, liver, lodge- tein kinase C isoforms, 69 ment, 83 280 Serum-free medium, tumorigenicity, cultured isothiocyanate (PEITC), 6-phenylhexyl isothiocyanate keratinocytes, cultured skin grafts, burns, skin car- (PHITC), 4-(methylnitrosamino)-1-(3-pyridyl)-1- cinoma, 141 butanone (NNK), 77 SHE clonal transformation, mezerein, tumor promoter, Transformed cell lines, antiproliferative effect, retinoids, 159 cytokines, combination therapy, 167 Skin, tumor, promotion, sphingosine, 35 Trichloroacetonitrile, halogenated acetonitriles, chlorina- Skin carcinoma, tumorigenicity, cultured keratinocytes, tion by-products, DNA adduct, protein adduct, 1 serum-free medium, cultured skin grafts, burns, 141 Tumor, skin, promotion, sphingosine, 35 Somatostatin analog carrying cytotoxic radical pancreatic Tumor, spontaneous, neoplams, F-344, rat, rodent, 49 cancer somatostatin methotrexate 263 Tumorigenicity, cultured keratinocytes, serum-free Somatostatin pancreatic cancer somatostatin analog car- medium, cultured skin grafts, burns, skin carcinoma, rying cytotoxic radical methotrexate 263 141 Sphingosine, skin, tumor, promotion, 35 Tumor immunity, human monoclonal antibody, antibody Spontaneous, neoplams, tumor, F-344, rat, rodent, 49 dependent cell-mediated cytotoxicity, anti-cancer an- Stress, mammary tumor virus, immunity, alprazolam, anx- tibody, cytotoxicity, effector cell, 179 iolytics, 185 Tumor promoter, mezerein, SHE clonal transformation, Suramin, insulin-like growth factor I, autorcine loop, dif- 159 ferentiation, human colon cancer cells, 23 Tumour cells, serotonin (5-HT), phagocytes, liver, lodge- Syrian golden hanster, cholecystokinin, pancreatic ment, 83 neoplasm, DNA aklyation, BOP, 251 Vegetarians, fecapentaenes, fecal mutagenicity, dietary Thaliblastine, cisplatin resistance, collateral sensitivity, rat components, omnivores, 11 ovarian tumor cell lines, 173 Vitamin A, fat, lung carcinogenesis, N-nitrosodiethylamine, Tobacco-specific nitrosoamine, isothiocyanates, phenethyl 57 Cancer Letters, 62 (1992) 281-282 Elsevier Scientific Publishers Ireland Ltd. Author Index Volume 62 Abe, T. Foreman, T.J. Adrian, T.E. Freire-Garabal, M. Amin, S.G. Frey, J.R. Antony, M. Frith; C.F. Avignolo, C. Fu, PP. Fujimoto, H. Bagge, U. Furmanski, P. Baghdiguian, S. Balboa, J.L. Gandhi, R.K. Banerjee, S. Geido, E. Barnett, T. Geisler, V. Bausch-Goldbohm, R.A. Gerard, C. Belmonte, A. Giaretti, W. Billings, P.C. Gollapudi, S. Birt, D.F. Gupta, R.C. Bjursten, L.-M. Gupta, S. Bollag, W. Boyce, S.T. Hagiwara, H. Bubenkk, J. Hansbrough, J.F. Bubenfkova, D. Hyodoh, F. Bucci, T. lizuka, S. Caignard, A. Indrova, M. Chandra, M. Ishizaka, Y. Chen, G. Childress-Fields, K.E. Jain, V. Chu, C.-Y. Jandlova, T. Chung, F.-L. Kadlubar, F.F. Clarke, C.L. Corra, S. Kanayama, Y. Kawaguchi, T. Daniel, F.B. Kazahaya, J. Das, N.P. Kazakoff, K. de Kok, T.M.C.M. Kennedy, A.R. Di Vinci, A. Khanduja, K.L. Dooley, K.L. Kikuchi, T. Kim, Y.S. Eklind, K.1. Kinugawa, K. Enkvetchakul, B. Kleinjans, J.C.S. Kodera, Y. Koul, I.B. Fantini, J. 282 Krieg Jr., E.F. Schally, A.V. Sehgal, S. Lau, B.H.S. Sennerby, L. Lawson, T.A. Sharma, R.R. im: E.2.C. Sheid, B. Liotta, D.C. Shirato, R. Lotzova, E. Shukla, Y. Simova, J. Maki, P.A. Sindoh, S. Makino, H. Skolnik, G. Matsushima, K. Spalding, J.W. Mehrotra, N.K. St. Clair, W.H. Menaldino, D. Suarez, J.A. Merrill Jr., A.H. Sugie, S. Minks, M. Sugimura, T. Monteith, D.K. Suzuki, K. Mori, H. Szoke, B. Mori, Y. Morishita, Y. Tan, C.H. Morse, M.A. Tanaka, T. Mortel, R. Taniguchi, M. Motomiya, M. Taniguchi, N. Taylor, C.W. Nagao, J. Teel, R.W. Nagao, M. ten Hoor, F. Nagy, A. Tennant, R.W. Nakao, H. Todorov, D.K. Nannmark, U. Tomita, M. Narumi, K. Tseng, T.-H. Nishiura, T. Tsushima, H. Nanez, M.J. Tu, A.S. Ochiai, M. Ueki, A. Ohno, R. Onda, M. van Faassen, A. Osumi, K. Verrier, B. Von Tungeln, L.S. Patel, K. Peck, R. Wang, C.-J. Pour, P.M. Weigel, W.W. Wong, B.Y.Y. Radulovic, S. Ramanathan, R. Rao, A.R. Yeoman, L.C. Reddy, T.V. Yonezawa, T. Yoshimi, N. Yuasa, H. Sakai, T. Satoh, K. Satyaswaroop, P.G. Zaino, R.J. Savage Jr., R.E. Zeller, W. Jens a